Up-regulate HLA Class I Expression Following Hepatitis B Virus Transfection in a Hepatocellular Carcinoma Cell Line BEL7405

REFERENCES

• Chang, C.C., Campoli, M., Ferrone, S. (2005). Classical and nonclassical HLA class I antigen and NK cell-activating ligand changes in malignant cells: current challenges and future directions. Adv. Cancer Res. 93:189–234.
   PubMed Web of Science ®Google Scholar
• Chen, M., Peng, M.L., Shi, Q.F., Ren, H. (2007). Establishing a L02 cell model with whole HBV gene transfection and analyzing its expressions of HLA-A, B, C and MICA/B. Zhonghua Gan Zang Bing Za Zhi. 15:417–421.
   PubMedGoogle Scholar
• Chen, Y., Cheng, M., Tian, Z. (2006). Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell Mol. Immunol. 3:373–378.
   PubMed Web of Science ®Google Scholar
• Diepstra, A., Poppema, S., Boot, M., Visser, L., Nolte, I.M., Niens, M., Te Meerman, G.J., van den Berg, A. (2008). HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens 71:219–226.
   PubMedGoogle Scholar
• Doolan, D.L., Hoffman, S.L. (1999). IL-12 and NK cells are required forantigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J. Immunol. 163:884–892.
   PubMed Web of Science ®Google Scholar
• Fine, C.I., Han, C.D., Sun, X., Liu, Y., McCutcheon, J.A. (2002). Tobacco reduces membrane HLA class I that is restored by transfection with transporter associated with antigen processing 1 cDNA. J. Immunol. 169:6012–6019.
   PubMed Web of Science ®Google Scholar
• Georgopoulos, N.T., Proffitt, J.L., Blair, G.E. (2000). Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chains,TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b,16 and 18 E7 oncoproteins. Oncogene 19:4930–4935.
   PubMed Web of Science ®Google Scholar
• Jung, M.C., Pape, G.R. (2001). Immunology of hepatitis B infection. Lancet Infect. Dis. 2:43–50.
   Web of Science ®Google Scholar
• Kerstin, H., Christine, S.F., Jens, E.. (2003). Up-regulation of major histocompatibility complex class i on liver cells by Hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J virol. 77: 8299–8309.
   PubMed Web of Science ®Google Scholar
• King, N.J.C., Kesson, A.M. (2003). Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response. Immunol. Cell Biol. 81:207.
   PubMed Web of Science ®Google Scholar
• LeBouder, F., Khoufache, K., Menier, C., Mandouri, Y., Keffous, M., Lejal, N., Krawice-Radanne, I., Carosella, E.D., Rouas-Freiss, N., Riteau, B. (2009). Immunosuppressive HLA-G molecule is up-regulated in alveolar epithelial cells after influenza A virus infection. Hum. Immunol. 70:1016–1019.
   PubMed Web of Science ®Google Scholar
• Le Bouteiller, P. (1994). HLA class I chromosomal region, genes, and products: facts and questions. Crit. Rev. Immunol.14:89–129.
   PubMed Web of Science ®Google Scholar
• Le Bouteiller, P., Blaschitz, A. (1999). The functionality of HLA-G is emerging. Immunol Rev. 167: 233–244.
   PubMed Web of Science ®Google Scholar
• Liu, Z.X., Govindarajan, S., Okamoto, S., Dennert, G. (2000). NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J, Immunol. 164:6480–6486.
   PubMed Web of Science ®Google Scholar
• Matsui, M., Ikeda, M., Akatsuka, T. (2001). High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem. Biophys. Res. Commun. 280:1008–1014.
   PubMed Web of Science ®Google Scholar
• Moretta, L., Mingari, M.C., Bottino, C., Pende, D., Biassoni, R, Moretta, A. (2003). Cellular and molecular basis of natural killer and natural killer-like activity. Immunol. Lett. 88:89–93.
   PubMed Web of Science ®Google Scholar
• Nayersina, R., Fowler, P., Guilhot, S. (1993). HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659–4671.
   PubMed Web of Science ®Google Scholar
• Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F.A., Avril, M.F., Dausset, J., Guillet, J.G., Carosella, E.D. (1998). HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc. Natl. Acad. Sci. USA 95:4510–4515.
   PubMed Web of Science ®Google Scholar
• Rose, M.J., Brooks, A.G., Stewart, L.A., Nguyen, T.H., Schwarer, A.P. (2009). Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro. J. Immunol. 183:4502–4508.
   PubMed Web of Science ®Google Scholar
• Shen, Y., Xia, M., Zhang, J., Xu, L., Yang, J., Chen, A., Miao F, Ferrone S, Xie W. (2009). IRF-1 and p65 mediate up-regulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells Mol. Immunol. 46:2045–2053.
   PubMed Web of Science ®Google Scholar
• Singal, D.P., Ye, M., Bienzle, D. (1998). Transfection of TAP 1 gene restores HLA class I expression in human small-cell lung carcinoma. Int. J. Cancer 75:112–116.
   PubMed Web of Science ®Google Scholar
• Stolarz, W., Wiczkowski, A., Vdojnicz, R. (1999). The HLA-I and HLA-II expression evaluation in liver biopsy specimens of patients with chronic viral hepatitis. Przegl Epidermiol.1999;53:385–393.
   Google Scholar
• Su, H.C., Ishikawa, R., Biron, C.A. (1993). Transforming growth factor beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J. Immunol. 151:4874–4890.
   PubMed Web of Science ®Google Scholar
• Vitale, M., Rezzani, R., Rodella, L. (1998). HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 58:737–742.
   PubMed Web of Science ®Google Scholar
• World Health Organization. HepatitisB. Cited 10 Nov 2008. Available from URL: www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/.
   Google Scholar